Influence of chelators and iron ions on the production and degradation of H2O2 by β-amyloid-copper complexes

被引:21
作者
Deraeve, Celine [1 ]
Pitie, Marguerite [1 ]
Meunier, Bernard [1 ]
机构
[1] CNRS, Chim Coordinat Lab, F-31077 Toulouse 4, France
关键词
Alzheimer's disease; beta-amyloid; H2O2; copper; chelator; chelating;
D O I
10.1016/j.jinorgbio.2006.08.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
beta-Amyloid peptide (A beta) 1-42, involved in the pathogenesis of Alzheimer's disease, binds copper ions to form A beta (.) Cu-n complexes that are able to generate H2O2 in the presence of a reductant and O-2. The production of H2O2 can be stopped with chelators. More reactive than H2O2 itself, hydroxyl radicals HO. (generated when a reduced redox active metal complex interacts with H2O2) are also probably involved in the oxidative stress that creates brain damage during the disease. We report in the present work a method to monitor the effect of chelating agents on the production of hydrogen peroxide by metallo-amyloid peptides. The addition of H2O2 associated to a pre-incubation step between ascorbate and A beta (.) Cu-n allows to study the formation of H2O2 but also, at the same time, its transformation by the copper complexes. A beta (.) Cu-n peptides produce but do not efficiently degrade H2O2. The reported analytic method, associated to precipitation experiments of copper-containing amyloid peptides, allows to study the inhibition of H2O2 production by chelators. The action of a ligand such as EDTA is probably due to the removal of the copper ions from A beta (.) Cu-n, whereas bidentate ligands such as 8-hydroxyquinolines probably act via the formation of ternary complexes with A beta (.) Cu-n. The redox activity of these bidentate ligands can be modulated by the incorporation or the modification of substituents on the quinoline heterocycle. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:2117 / 2126
页数:10
相关论文
共 30 条
[1]   Amyloid-β:: a chameleon walking in two worlds:: a review of the trophic and toxic properties of amyloid-β [J].
Atwood, CS ;
Obrenovich, ME ;
Liu, TB ;
Chan, H ;
Perry, G ;
Smith, MA ;
Martins, RN .
BRAIN RESEARCH REVIEWS, 2003, 43 (01) :1-16
[2]   Dramatic aggregation of Alzheimer Aβ by Cu(II) is induced by conditions representing physiological acidosis [J].
Atwood, CS ;
Moir, RD ;
Huang, XD ;
Scarpa, RC ;
Bacarra, NME ;
Romano, DM ;
Hartshorn, MK ;
Tanzi, RE ;
Bush, AI .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (21) :12817-12826
[3]   Characterization of copper interactions with Alzheimer amyloid β peptides:: Identification of an attomolar-affinity copper binding site on amyloid β1-42 [J].
Atwood, CS ;
Scarpa, RC ;
Huang, XD ;
Moir, RD ;
Jones, WD ;
Fairlie, DP ;
Tanzi, RE ;
Bush, AI .
JOURNAL OF NEUROCHEMISTRY, 2000, 75 (03) :1219-1233
[4]   Neurodegenerative diseases and oxidative stress [J].
Barnham, KJ ;
Masters, CL ;
Bush, AI .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (03) :205-214
[5]   Tyrosine gated electron transfer is key to the toxic mechanism of Alzheimer's disease β-amyloid [J].
Barnham, KJ ;
Haeffner, F ;
Ciccotosto, GD ;
Curtain, CC ;
Tew, D ;
Mavros, C ;
Beyreuther, K ;
Carrington, D ;
Masters, CL ;
Cherny, RA ;
Cappai, R ;
Bush, AI .
FASEB JOURNAL, 2004, 18 (10) :1427-+
[6]   Preparation of cyclo-phen-type ligands:: Chelators of metal ions as potential therapeutic agents in the treatment of neurodegenerative diseases [J].
Boldron, C ;
Van der Auwera, I ;
Deraeve, C ;
Gornitzka, H ;
Wera, S ;
Pitié, M ;
Van Leuven, F ;
Meunier, B .
CHEMBIOCHEM, 2005, 6 (11) :1976-1980
[7]   Metal complexing agents as therapies for Alzheimer's disease [J].
Bush, AI .
NEUROBIOLOGY OF AGING, 2002, 23 (06) :1031-1038
[8]   Treatment with a copper-zinc chelator markedly and rapidly inhibits β-amyloid accumulation in Alzheimer's disease transgenic mice [J].
Cherny, RA ;
Atwood, CS ;
Xilinas, ME ;
Gray, DN ;
Jones, WD ;
McLean, CA ;
Barnham, KJ ;
Volitakis, I ;
Fraser, FW ;
Kim, YS ;
Huang, XD ;
Goldstein, LE ;
Moir, RD ;
Lim, JT ;
Beyreuther, K ;
Zheng, H ;
Tanzi, RE ;
Masters, CL ;
Bush, AI .
NEURON, 2001, 30 (03) :665-676
[9]   Chelation and intercalation: Complementary properties in a compound for the treatment of Alzheimer's disease [J].
Cherny, RA ;
Barnham, KJ ;
Lynch, T ;
Volitakis, I ;
Li, QX ;
McLean, CA ;
Multhaup, G ;
Beyreuher, K ;
Tanzi, RE ;
Masters, CL ;
Bush, AI .
JOURNAL OF STRUCTURAL BIOLOGY, 2000, 130 (2-3) :209-216
[10]   Aqueous dissolution of Alzheimer's disease Aβ amyloid deposits by biometal depletion [J].
Cherny, RA ;
Legg, JT ;
McLean, CA ;
Fairlie, DP ;
Huang, XD ;
Atwood, CS ;
Beyreuther, K ;
Tanzi, RE ;
Masters, CL ;
Bush, AI .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (33) :23223-23228